Baylor College of Medicine: Phase 3 Clinical Trials for Investigational COVID-19 Vaccine Underway
July 28, 2020
July 28, 2020
HOUSTON, Texas, July 28 -- The Baylor College of Medicine issued the following news release:
Baylor College of Medicine's Vaccine and Treatment Evaluation Unit is one of approximately 90 sites selected to participate in the Phase 3 clinical trial for Moderna's investigational mRNA-1273 vaccine to evaluate the efficacy of the vaccine at preventing COVID-19 disease. Dr. Hana El Sahly, associate professor of molecular virology and microbiology and medicine at Baylor, serves as a nation . . .
Baylor College of Medicine's Vaccine and Treatment Evaluation Unit is one of approximately 90 sites selected to participate in the Phase 3 clinical trial for Moderna's investigational mRNA-1273 vaccine to evaluate the efficacy of the vaccine at preventing COVID-19 disease. Dr. Hana El Sahly, associate professor of molecular virology and microbiology and medicine at Baylor, serves as a nation . . .